690 related articles for article (PubMed ID: 29066063)
1. Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System.
Barbero F; Russo L; Vitali M; Piella J; Salvo I; Borrajo ML; Busquets-Fité M; Grandori R; Bastús NG; Casals E; Puntes V
Semin Immunol; 2017 Dec; 34():52-60. PubMed ID: 29066063
[TBL] [Abstract][Full Text] [Related]
2. The nanoparticle protein corona formed in human blood or human blood fractions.
Lundqvist M; Augustsson C; Lilja M; Lundkvist K; Dahlbäck B; Linse S; Cedervall T
PLoS One; 2017; 12(4):e0175871. PubMed ID: 28414772
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona.
Ahsan SM; Rao CM; Ahmad MF
Adv Exp Med Biol; 2018; 1048():175-198. PubMed ID: 29453539
[TBL] [Abstract][Full Text] [Related]
4. The "sweet" side of the protein corona: effects of glycosylation on nanoparticle-cell interactions.
Wan S; Kelly PM; Mahon E; Stöckmann H; Rudd PM; Caruso F; Dawson KA; Yan Y; Monopoli MP
ACS Nano; 2015 Feb; 9(2):2157-66. PubMed ID: 25599105
[TBL] [Abstract][Full Text] [Related]
5. Improving dispersal of therapeutic nanoparticles in the human body.
Limongi T; Canta M; Racca L; Ancona A; Tritta S; Vighetto V; Cauda V
Nanomedicine (Lond); 2019 Apr; 14(7):797-801. PubMed ID: 30895871
[No Abstract] [Full Text] [Related]
6. Interplay between nanomedicine and protein corona.
Yang M; Wu E; Tang W; Qian J; Zhan C
J Mater Chem B; 2021 Sep; 9(34):6713-6727. PubMed ID: 34328485
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-protein complexes mimicking corona formation in ocular environment.
Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH
Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757
[TBL] [Abstract][Full Text] [Related]
8. Intentional formation of a protein corona on nanoparticles: Serum concentration affects protein corona mass, surface charge, and nanoparticle-cell interaction.
Gräfe C; Weidner A; Lühe MV; Bergemann C; Schacher FH; Clement JH; Dutz S
Int J Biochem Cell Biol; 2016 Jun; 75():196-202. PubMed ID: 26556312
[TBL] [Abstract][Full Text] [Related]
9. Understanding the nanoparticle-protein corona complexes using computational and experimental methods.
Kharazian B; Hadipour NL; Ejtehadi MR
Int J Biochem Cell Biol; 2016 Jun; 75():162-74. PubMed ID: 26873405
[TBL] [Abstract][Full Text] [Related]
10. Protein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake.
Pustulka SM; Ling K; Pish SL; Champion JA
ACS Appl Mater Interfaces; 2020 Oct; 12(43):48284-48295. PubMed ID: 33054178
[TBL] [Abstract][Full Text] [Related]
11. Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier.
Cox A; Andreozzi P; Dal Magro R; Fiordaliso F; Corbelli A; Talamini L; Chinello C; Raimondo F; Magni F; Tringali M; Krol S; Jacob Silva P; Stellacci F; Masserini M; Re F
ACS Nano; 2018 Jul; 12(7):7292-7300. PubMed ID: 29953205
[TBL] [Abstract][Full Text] [Related]
12. Silver nanoparticle protein corona and toxicity: a mini-review.
Durán N; Silveira CP; Durán M; Martinez DS
J Nanobiotechnology; 2015 Sep; 13():55. PubMed ID: 26337542
[TBL] [Abstract][Full Text] [Related]
13. Protein Corona-Enabled Systemic Delivery and Targeting of Nanoparticles.
Chen D; Ganesh S; Wang W; Amiji M
AAPS J; 2020 Jun; 22(4):83. PubMed ID: 32495039
[TBL] [Abstract][Full Text] [Related]
14. How Corona Formation Impacts Nanomaterials as Drug Carriers.
Gupta MN; Roy I
Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
[TBL] [Abstract][Full Text] [Related]
15. How protein coronas determine the fate of engineered nanoparticles in biological environment.
Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
[TBL] [Abstract][Full Text] [Related]
16. Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.
Raesch SS; Tenzer S; Storck W; Rurainski A; Selzer D; Ruge CA; Perez-Gil J; Schaefer UF; Lehr CM
ACS Nano; 2015 Dec; 9(12):11872-85. PubMed ID: 26575243
[TBL] [Abstract][Full Text] [Related]
17. Specifically Formed Corona on Silica Nanoparticles Enhances Transforming Growth Factor β1 Activity in Triggering Lung Fibrosis.
Wang Z; Wang C; Liu S; He W; Wang L; Gan J; Huang Z; Wang Z; Wei H; Zhang J; Dong L
ACS Nano; 2017 Feb; 11(2):1659-1672. PubMed ID: 28085241
[TBL] [Abstract][Full Text] [Related]
18. Surface roughness influences the protein corona formation of glycosylated nanoparticles and alter their cellular uptake.
Piloni A; Wong CK; Chen F; Lord M; Walther A; Stenzel MH
Nanoscale; 2019 Dec; 11(48):23259-23267. PubMed ID: 31782458
[TBL] [Abstract][Full Text] [Related]
19. Formation and Characterization of Protein Corona Around Nanoparticles: A Review.
Pareek V; Bhargava A; Bhanot V; Gupta R; Jain N; Panwar J
J Nanosci Nanotechnol; 2018 Oct; 18(10):6653-6670. PubMed ID: 29954482
[TBL] [Abstract][Full Text] [Related]
20. Formation and biological effects of protein corona for food-related nanoparticles.
Cui G; Su W; Tan M
Compr Rev Food Sci Food Saf; 2022 Mar; 21(2):2002-2031. PubMed ID: 34716644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
